WAYNE, Pa.--Escalon Medical (Nasdaq:
ESMC) had net revenues of $26.9 million in its fourth quarter ended
June 30, an 82.9 percent increase over fiscal 2004’s Q4.
The increase was primarily attributable to revenues resulting from
the July 2004 acquisition of Drew Scientific Group, the company
said. Product revenue increased 93.3 percent, to $23.8 million, in
fiscal 2005, primarily attributable to Drew.
October 2005
Latest News